fda warning letter semaglutide october 2025 Drug compounders sue over declaration ending Wegovy shortage FDA Sends Warning Letters to

Compounded products have not been evaluated by the FDA for safety, effectiveness, or quality in the same manner as FDA-approved drugs

If the appeal is denied or you prefer not to wait, PlexusDx provides an immediate alternative: compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan, available in all 50 states without prior authorization

10.3389/fnmol.2021.697440 45 MarsoS

Finally, confounding factors such as diet, physical activity, and medication use are not always adequately controlled, which may bias interpretations of hormonal effects

That is not a reason to dismiss treatment

An observational study of obese T2D patients with concurrent MASLD (metabolic dysfunction-associated steatotic liver disease) showed that 12 weeks of liraglutide significantly increased gut bacterial diversity and shifted the community toward a profile more like healthy individuals (39)